Brits first to get new obesity drug

	Tweet

A new drug to combat obesity will shortly be available in Britain.

The drug Acomplia is a new weight loss preparation that curbs the desire to over-eat and British patients will be the first worldwide to access the medication.

Trials of the drug have shown as much as a 10 per cent body weight reduction can be achieved within a year, which reduces the risk of diabetes and heart disease.

The drug is targeted at obese people to help them loose extra pounds and experts are predicting that the revolutionary drug could benefit millions of obese Britons.

There are some concerns that access to the drug on the NHS will be delayed because it has not as yet been assessed by rationing watchdogs.

Acomplia, also known as Rimonabant is one of a new generation of drugs designed to curb craving and needs to be taken each day before breakfast.

The pill, will be available on prescription from today at a cost of ?55.20 ($100) a month following official European Union marketing approval last week.

It is also expected to be available soon in Denmark, Ireland, Germany, Finland and Norway later on in the year.

Millions could benefit from the potential blockbuster, as more than half the adult population is obese or overweight.

Within hours of the launch announcement in London, at least one online Canadian pharmacy was advertising a four-week supply of the drug for $165.

Sanofi-Aventis says the ideal patient for Acomplia is overweight with type two diabetes or low levels of good cholesterol (HDL) or high levels of bad blood fats; it will benefit such patients the most because it will also provide improvement above and beyond weight loss alone.

Acomplia is made by the French pharmaceutical firm Sanofi-Aventis which is applying for licenses to market the drug in the U.S.

RELATED STORIES:
Weight in pregnancy best controlled by diet, study shows   FDA advisers recommend approving weight loss drug   Bridal Hunger Games   Exercise, Group Support Work for Weight Loss   Misperception of weight is an important barrier to weight loss   Obesity drugs need heart studies, U.S. advisers say   Weight Loss Surgery and Diabetes: Expert Interview Opportunity   New evidence on effects of green coffee beans in weight loss   Chocolate lovers tend to weigh less: study   Weight loss won’t necessarily help teen girls’ self-esteem   How to Best Help Your Child Lose Weight: Lose Weight Yourself   Qnexa: Is the new anti-obesity drug too risky?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]